PMID- 36456431
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230803
IS  - 2529-993X (Electronic)
IS  - 2529-993X (Linking)
VI  - 41
IP  - 7
DP  - 2023 Aug-Sep
TI  - Adverse events in pregnant women with the tetravalent influenza vaccine obtained 
      from cell cultures.
PG  - 420-422
LID - S2529-993X(22)00254-4 [pii]
LID - 10.1016/j.eimce.2022.11.005 [doi]
AB  - Influenza vaccination in pregnant women shows a clear benefit/risk ratio. 
      Influenza vaccines are currently being developed using new platforms. It is 
      essential to analyse the safety of these new vaccines in this population group, 
      underrepresented in clinical trials. In the 2019-2020 season, a vaccine obtained 
      in cell culture was recommended to pregnant women in two autonomous communities. 
      Information is collected from the vaccination and pharmacovigilance centres of 
      both communities. The reporting rate of adverse events (AEs) after vaccination in 
      pregnant women was 4.02/100,000 doses administered, and in non-pregnant women 
      aged 18-64 years it was 5.9/100,000 doses administered. The rate of AE reported 
      was 8.04 and 17.74 respectively. No spontaneous abortions, prematurity or foetal 
      malformations were reported. This analysis suggests the safety in pregnant women 
      of the influenza vaccine obtained from cell cultures.
CI  - Copyright (c) 2022. Published by Elsevier Espana, S.L.U.
FAU - Carreras, Juan Jose
AU  - Carreras JJ
AD  - Area de Investigacion en Vacunas, FISABIO - Salud Publica, Valencia, Spain.
FAU - Lluch, Jose Antonio
AU  - Lluch JA
AD  - Direccion General de Salud Publica y Adicciones, Conselleria de Sanitat Universal 
      i Salut Publica, Valencia (Comunidad Valenciana), Spain.
FAU - Taboada, Jose Antonio
AU  - Taboada JA
AD  - Programa Galego de Vacinacion, Direccion Xeral de Saude Publica, Conselleria de 
      Sanidade, Santiago de Compostela (Galicia), Spain.
FAU - Pastor-Villalba, Eliseo
AU  - Pastor-Villalba E
AD  - Direccion General de Salud Publica y Adicciones, Conselleria de Sanitat Universal 
      i Salut Publica, Valencia (Comunidad Valenciana), Spain.
FAU - Nartallo-Penas, Victoria
AU  - Nartallo-Penas V
AD  - Programa Galego de Vacinacion, Direccion Xeral de Saude Publica, Conselleria de 
      Sanidade, Santiago de Compostela (Galicia), Spain.
FAU - Diez-Domingo, Javier
AU  - Diez-Domingo J
AD  - Area de Investigacion en Vacunas, FISABIO - Salud Publica, Valencia, Spain. 
      Electronic address: Javier.diez@fisabio.es.
LA  - eng
PT  - Journal Article
DEP - 20221128
PL  - Spain
TA  - Enferm Infecc Microbiol Clin (Engl Ed)
JT  - Enfermedades infecciosas y microbiologia clinica (English ed.)
JID - 101777541
SB  - IM
OTO - NOTNLM
OT  - Adverse drug events
OT  - Adverse drug reaction reporting systems
OT  - Drug safety
OT  - Efectos adversos de los medicamentos
OT  - Farmacoepidemiologia
OT  - Flu vaccines
OT  - Pharmacoepidemiology
OT  - Seguridad de los medicamentos
OT  - Sistemas de notificacion de reacciones adversas a los medicamentos
OT  - Vaccination
OT  - Vacunacion
OT  - Vacunas contra la gripe
EDAT- 2022/12/02 06:00
MHDA- 2022/12/02 06:01
CRDT- 2022/12/01 22:08
PHST- 2021/11/09 00:00 [received]
PHST- 2022/02/03 00:00 [revised]
PHST- 2022/02/10 00:00 [accepted]
PHST- 2022/12/02 06:01 [medline]
PHST- 2022/12/02 06:00 [pubmed]
PHST- 2022/12/01 22:08 [entrez]
AID - S2529-993X(22)00254-4 [pii]
AID - 10.1016/j.eimce.2022.11.005 [doi]
PST - ppublish
SO  - Enferm Infecc Microbiol Clin (Engl Ed). 2023 Aug-Sep;41(7):420-422. doi: 
      10.1016/j.eimce.2022.11.005. Epub 2022 Nov 28.